EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Platelet‐rich plasma injections for the management of knee osteoarthritis: The ESSKA‐ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios

Elizaveta Kon, Laura de Girolamo, Lior Laver, Luca Andriolo, Isabel Andia, Ricardo Bastos, Philippe Beaufils, Leela Biant, Berte Bøe, Angelo Boffa, Ramon Cugat, Alessandro Di Martino und 15 weitere

Knee Surgery, Sports Traumatology, Arthroscopy · 2024-11 · 32 (11) · 2938-2949

DOI: 10.1002/ksa.12320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 04.07.2024. Verfasst von Elizaveta Kon und 26 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Center, Rozzano, Milan, Italy. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Osteoarthritis, Knee. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The aim of this consensus was to develop evidence‐ and expert‐based patient‐focused recommendations on the appropriateness of intra‐articular platelet‐rich plasma (PRP) injections in different clinical scenarios of patients with knee osteoarthritis (OA).

Methods

The RAND/UCLA Appropriateness Method was used by the European Society of Sports Traumatology, Knee Surgery, and Arthroscopy (ESSKA), as well as the International Cartilage Regeneration and Joint Preservation Society (ICRS) to reach a consensus and produce recommendations for specific patient categories combining best available scientific evidence with the collective judgement of a panel of experts.

Results

Scenarios were defined based on first treatment vs first injective treatment vs second injective treatment, age (80), tibiofemoral vs patellofemoral involvement, OA level (Kellgren–Lawrence/KL 0–I/II–III/IV), and joint effusion (dry knee, minor‐mild or major effusion). Out of 216 scenarios, in 84 (38.9%) the indication was considered appropriate, in 9 (4.2%) inappropriate and in 123 (56.9%) uncertain. The parameters associated with the highest consensus were PRP use after failed injective treatments (62.5%), followed by PRP after failed conservative treatments and KL 0–III scenarios (58.3%), while the highest uncertainty was found for PRP use as first treatment and KL IV OA (91.7% and 87.5% of uncertain scenarios, respectively).

Conclusion

This ESSKA‐ICRS consensus established recommendations on the appropriateness or inappropriateness of PRP injections for the treatment of knee OA, providing a useful reference for clinical practice. PRP injections are considered appropriate in patients aged ≤80 years with knee KL 0–III OA grade after failed conservative non‐injective or injective treatments, while they are not considered appropriate as first treatment nor in KL IV OA grade. Level of Evidence Level I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaOsteoarthritis, KneeHumansInjections, Intra-ArticularMiddle AgedAgedAged, 80 and overFemaleMale

Stichwörter der Autor:innen

OAconsensuskneeosteoarthritisplatelet‐rich plasma

Autor:innen und Institutionen

  • IRCCS Humanitas Research Center, Rozzano, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • IRCCS Ospedale Galeazzi Sant'Ambrogio, Orthopaedic Biotechnology Laboratory, Milano, Italy.
  • Department of Orthopaedics, Hillel Yaffe Medical Center (HYMC), Hadera, Israel.
  • Rappaport Faculty of Medicine, Technion University Hospital, Israel Institute of Technology, Haifa, Israel.
  • Arthrosport Clinic, Tel-Aviv, Israel.

Förderung

  • None

Zitieren

APA

Kon, E., de Girolamo, L., Laver, L., Andriolo, L., Andia, I., Bastos, R., Beaufils, P., Biant, L., Bøe, B., Boffa, A., Cugat, R., Di Martino, A., Erggelet, C., Iosifidis, M., Kocaoglu, B., Magalon, J., Marinescu, R., Nehrer, S., Niemeyer, P., …, & Filardo, G. (2024). Platelet‐rich plasma injections for the management of knee osteoarthritis: The ESSKA‐ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 32(11), 2938-2949. https://doi.org/10.1002/ksa.12320

Vancouver

Kon E, de Girolamo L, Laver L, Andriolo L, Andia I, Bastos R, et al. Platelet‐rich plasma injections for the management of knee osteoarthritis: The ESSKA‐ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy. 2024;32(11):2938-2949. doi:10.1002/ksa.12320

BibTeX
@article{Kon2024,
  author = {Kon, Elizaveta and de Girolamo, Laura and Laver, Lior and Andriolo, Luca and Andia, Isabel and Bastos, Ricardo and Beaufils, Philippe and Biant, Leela and Bøe, Berte and Boffa, Angelo and Cugat, Ramon and Di Martino, Alessandro and Erggelet, Christoph and Iosifidis, Michael and Kocaoglu, Baris and Magalon, Jérémy and Marinescu, Rodica and Nehrer, Stefan and Niemeyer, Philipp and Ostojić, Marko and Piontek, Tomasz and Sánchez, Mikel and Sas, Kristof and Skarpas, Georges and Tischer, Thomas and Vonk, Lucienne and Filardo, Giuseppe},
  title = {Platelet‐rich plasma injections for the management of knee osteoarthritis: The ESSKA‐ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2024},
  volume = {32},
  number = {11},
  pages = {2938--2949},
  doi = {10.1002/ksa.12320}
}
Kostenlos starten →